DekaBank Deutsche Girozentrale - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 126 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$293,000
-24.9%
102,1000.0%0.00%0.0%
Q2 2021$390,000
+23.0%
102,1000.0%0.00%0.0%
Q1 2021$317,000
+13.6%
102,1000.0%0.00%0.0%
Q4 2020$279,000
+16.7%
102,1000.0%0.00%0.0%
Q3 2020$239,000
-60.6%
102,100
-30.6%
0.00%
-75.0%
Q3 2019$606,000
-59.6%
147,100
-54.6%
0.00%
-50.0%
Q2 2019$1,501,000
+782.9%
324,200
+1473.8%
0.01%
+700.0%
Q1 2019$170,000
+78.9%
20,600
+20.5%
0.00%0.0%
Q4 2018$95,000
-44.1%
17,100
-17.0%
0.00%0.0%
Q3 2018$170,000
-11.9%
20,6000.0%0.00%0.0%
Q2 2018$193,000
-4.0%
20,6000.0%0.00%0.0%
Q1 2018$201,000
+32.2%
20,600
+21.2%
0.00%
-50.0%
Q1 2016$152,000
-18.7%
17,000
+15.6%
0.00%0.0%
Q4 2015$187,000
+33.6%
14,700
+1.4%
0.00%0.0%
Q3 2015$140,000
+0.7%
14,500
+7.4%
0.00%0.0%
Q2 2015$139,000
+31.1%
13,500
+42.1%
0.00%
+100.0%
Q1 2015$106,0009,5000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders